COMPARATIVE ASSESSMENT OF QUALITY OF IMMUNORADIOMETRIC ASSAY (IRMA) AND CHEMILUMINESCENCE IMMUNOMETRIC ASSAY (CHEIMA) FOR ESTIMATION OF THYROID STIMULATING HORMONE (TSH)

Authors

  • K. M. Sajid Multan Institute of Nuclear Medicine and Radiotherapy (MINAR), P.O. Box 377, Multan, Pakistan

Abstract

Biological substances like hormones, vitamins and enzymes are found in minute quantities in blood. Their estimation requires very sensitive and specific methods. The most modern method for estimation of thyroid stimulating hormone in serum is non-isotopic enzyme enhanced chemiluminescence immunometric method. In our laboratory immunoradiometric assay is in routine for the last many years. Recently interest has grown to establish non-isotopic techniques in laboratories of PAEC. However, the main requirement to adopt the new procedures is to compare their results, cost and other benefits with the existing method. Immunoassay laboratory of MINAR, therefore, conducted a study to compare the two methods. A total of 173 (males: 34 females: 139 age: between 1 and 65 years) cases of clinically confirmed thyroid status were included in the study. Serum samples of these cases were analyzed by two methods and results were compared by plotting precision profiles, correlation plots and calculating sensitivities and specificities of the methods. As the results in all the samples were not normally distributed Wilcoxon rank sum test was applied to compare the analytical results of two methods. The comparison shows that the results obtained in two methods are not completely similar (p=0.0003293), although analysis of samples in groups shows that some similarity exists between the results of hypo and hyperthyroid patients (p<=0.156 and p<=0.6138). This shows that results obtained in these two methods could sometimes disagree in final diagnosis. Although TSH-CHEIMA is analytically more sensitive than TSH-IRMA the clinical sensitivities and specificities of two methods are not significantly different. TSHCHEIMA test completes in almost 2 hours whereas TSH-IRMA takes about 6 hours to complete. Comparison of costs shows that TSH-CHIEMA is almost 5 times more expensive than TSH-IRMA. We conclude that the two methods could sometimes disagree but the two techniques have almost same clinical efficacy (clinical usefulness). The clinical sensitivities and specificities are similar and TSH-IRMA is in no way inferior to the non-isotopic method. It is, therefore, not reasonable to abandon a good technique only for relatively speedy results.

References

C. K. Mathews and K. E. van Holde, In: D.

Bowen(ed), Biochemistry. The Benjamin/

Cummings publishing group (1990) pp. 790–

A. L. Smith et al. (Ed). Oxford dictionary of

biochemistry and molecular biology. Oxford

[Oxfordshire]: Oxford University Press.

(1997).

S. A. Berson and R. S. Yalow, J. Clin. Invest.

(1957) 876.

W. P. Collins, G. J. Bernard, J. B. Kim, D. A.

Weerasekera, F. Kohen, Z. Eshhar and H. R.

Linder. In: W.M. Hunter, JET Corrie, (eds)

Immunoassays for Clinical Chemistry.

Edinburgh:Churchill Livingstone Ch. 9 (1983)

pp. 373-397.

Obituary. The endocrinologist. The newsletter of the society for endocrinology. Issue

Spring (2006).

E. Martino G, BambinI, S L. Bartalena

Claudia, Mammoli F. Aghini-Lombardi L.

Baschieri and A. Pinchera, Clinical

Endocrinology 24 (1986) 141.

David Wild (ed). Introduction. In: The

immunoassay Hand Book. Part-II.

Stockholme Press. Newyork, USA. (1994)

p.137-142.

R. Lynn and M. D. Witherspoon, Clinical Lab.

Med; American Society for Clinical

Pathology. 36, No. 11 (2005) 711.

J. H. McBride, R. V. Thibeault and D. O.

Rodgerson (eds). Clinical Chemistry,

American Association for Clinical Chemistry

(1985) 1865,

E. Taimela, M. Aalto, J. Viikari, P. Nuutila

and K. Irjala. Scandinavian Journal of Clinical

and Laboratory Investigation, 55, No. 6

(1995) 537 - 541 DOI: 10.3109/0036551950-

T. Hashimoto, F. Matsubara , M. Nishibu and

K. Kawai. Eur. J. Clin. Chem. Clin. Biochem.

No. 11 (1991) 753.

J.L. Schlienger, R. Sapin, F. Grunenberger,

F. Gasser and A. Pradignac. Pathol. Biol.

(Paris) 41, No. 5 (1993) 463.

IMMULITE®

Chemiluminescent Technology

Proprietary Wash Technique. Siemens

Health Care Diagnostics in 2007-2009.

M. M. Rauhut, Chemiluminescence. In:

Grayson, Martin (Ed). Kirk-Othmer Concise

Encyclopedia of Chemical Technology (3rd

ed), John Wiley and Sons (1985) p. 247.

C. A. Spencer et al. Clin. Chem. 41. (1995)

National committee for clinical laboratory

standards, procedures for the collection of

blood specimens by venipuncture; approved

standard 4

IMMULITE. Third Generation TSH. For use

on the immulite@ 1000 systems (assay

procedure). Diagnostic Products Corporation,

USA (2008). th edition NCCLS Document

Directions for use. Immunotech, IVD. TSH H3-A4. Wayne, PA NCLLS (1998).

IRMA KIT REF. IM3712-IM3713. Immunometeric assay for the in Vitro determination of

Thyroid stimulating hormone in human sera

and plasma (2008).

J. Catharine Scott-Moncrieff, A. Koshko

Mark, A. Brown Jennifer, Hill Kate and

R. Refsal Kent, Veterinary Clinical Pathology.

Volume 32 issue 4, pages 180-187.

Published on line. 5 March 2008. @ 2009

The American Society for veterinary clinical

pathology (2008).

A. L. Babson. Cirrus, J. Clin. Immunoassay

(1991) 83.

G.G. Klee, I.D. J. Clin. Endcrinol. Metab. 64,

No. 3. (1987) 461.

Downloads

Published

26-06-2020

How to Cite

[1]
K. M. Sajid, “COMPARATIVE ASSESSMENT OF QUALITY OF IMMUNORADIOMETRIC ASSAY (IRMA) AND CHEMILUMINESCENCE IMMUNOMETRIC ASSAY (CHEIMA) FOR ESTIMATION OF THYROID STIMULATING HORMONE (TSH)”, The Nucleus, vol. 46, no. 4, pp. 487–494, Jun. 2020.

Issue

Section

Articles